Dyadic International Inc at ROTH Conference Transcript
Okay, we are going to move on to our next presentation from Dyadic International, ticker DYAI, an approximately $80 million market cap company focused on innovative manufacturing for biotechnology, among other things. Presenting for the Company is Mark Emalfarb, Chief Executive Officer, and the man that brought us stone washed jeans. So take it away, Mark, and thank you for coming to the ROTH conference.
Thank you for having me. Well, welcome, everybody. I see a lot of familiar faces and some new faces. The most important thing that we're doing at Dyadic is we are hoping to bring healthcare -- make it more affordable to people. And patients aren't getting access to drugs because of high prices and I think we have an ability to change the game in how those are developed and produced. So speed up the development and lower the cost.
The highlights, share price, $2.80 I guess a few days ago. I think it's a little higher today. A 52-week range, I think it's a little higher today. Market
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
